Cashu | News | VNDA

HomeWatchlistNewsSignalsPicks

DJI

+0.77%

SPX

+0.83%

IXIC

+0.98%

FTSE

+0.42%

N225

+0.77%

AXJO

+0.45%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Vanda Pharmaceuticals News

Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera

Feature Image for interests on Biotechnology, Clinical Trials & Medical Discoveries, Fda Approval, Health Care & Hospitals from prnewswire.com

Vanda Seeks FDA Commissioner Review of Outgoing CDER Director's Decision to Uphold Approval of Two Generic Versions of Hetlioz

Feature Image for interests on Fda Approval, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com

In a Major Win for Vanda, a Federal Appeals Court Overturns FDA's Order Denying Approval of Hetlioz for the Treatment of Jet Lag Disorder

Feature Image for interests on Fda Approval, Health Care & Hospitals, Healthcare, Legal Issues from prnewswire.com

businesswire.com

Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.

Feature Image for interests on Healthcare, Stock from businesswire.com

finance.yahoo.com

Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

Feature Image for interests on Alzheimer’S Disease, Clinical Trial, Financial Services, Healthcare from finance.yahoo.com

businesswire.com

Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share

Feature Image for interests on Healthcare, Stock, Technology from businesswire.com

finance.yahoo.com

Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today

Feature Image for interests on Food And Drug Administration, Gastroparesis, Healthcare, Skin Disorder from finance.yahoo.com

finance.yahoo.com

Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments

Feature Image for interests on Diabetic Gastroparesis, Evoke Pharma, Gastroparesis, Gimoti from finance.yahoo.com

finance.yahoo.com

FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis

Feature Image for interests on Expanded Access, Food And Drug Administration, Forward-Looking Statements, Healthcare from finance.yahoo.com

finance.yahoo.com

Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare Conference

Feature Image for interests on Cantor Global Healthcare Conference, Fireside Chat, Healthcare, Stock from finance.yahoo.com

Stocks

Health Care

vnda

Vanda Pharmaceuticals

NASDAQ: VNDA

-0.06 (-1.38%)

4.655

USD

At close at Sep 04, 20:39 UTC

Latest Cashu News

Vanda Pharmaceuticals Secures Orphan Drug Designation for VGT-1849B in Polycythemia Vera Treatment

Vanda Pharmaceuticals Secures FDA Orphan Drug Designation for Polycythemia Vera Treatment VGT-1849B

Vanda Pharmaceuticals Challenges FDA's Generic Drug Approvals for Hetlioz®